|Articles|September 1, 2009
- Applied Clinical Trials-09-01-2009
- Volume 0
- Issue 0
Applied Clinical Trials Digital Edition - September 2009
REGULATORY : Comprehensive Guide for Generic Drug Trials The Unique Concerns of Recombinant DNA Research TRIAL DESIGN : A Crash Course in Adaptive Also in this issue : Sponsors Challenged by Globalization, GCP Inspections Unite EMEA and FDA, Post Credit Crunch R&D Opportunities
Advertisement
Articles in this issue
over 16 years ago
The Spotlight Falls on Indiaover 16 years ago
eClinical Software: September 2009over 16 years ago
Into the Aftermath of M&Aover 16 years ago
EMEA and FDA Team Up on GCPover 16 years ago
Does Size Matter in Partnershipsover 16 years ago
An Assessment of Adaptiveover 16 years ago
Business and People Update September 2009over 16 years ago
eCTD Training Effortsover 16 years ago
Global Development Challenges Sponsorsover 16 years ago
Regulating the Generic Drug ProcessNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
2
Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions
3
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
4
SCOPE Summit 2026: ESG Shifts From Reporting Exercise to Vendor Readiness Test in Clinical Operations
5